| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone (NCT05033288) | Mayo Clinic | 2022-01-20 |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801) | M.D. Anderson Cancer Center | 2021-09-30 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors (NCT04673942) | EpicentRx, Inc. | 2021-03-29 |
| Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas (NCT04832620) | Leiden University Medical Center | 2021-02-02 |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations (NCT04521686) | Eli Lilly and Company | 2020-10-01 |
| Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers (NCT04553692) | IGM Biosciences, Inc. | 2020-09-23 |
| AG-120 in People With IDH1 Mutant Chondrosarcoma (NCT04278781) | Memorial Sloan Kettering Cancer Center | 2020-03-04 |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (NCT04055220) | Centre Leon Berard | 2020-03-03 |
| Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration (NCT04040205) | Medical College of Wisconsin | 2019-10-07 |
| Long-Term Longitudinal QoL in Patients Undergoing EEA (NCT04087902) | Ohio State University | 2019-07-16 |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas (NCT03442465) | Memorial Sloan Kettering Cancer Center | 2018-02-14 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial (NCT03173976) | Mohammed Milhem | 2017-07-18 |
| Low Grade Chondrosarcoma Versus Enchondroma (NCT02996747) | Istituto Ortopedico Rizzoli | 2016-08-01 |
| Metformin And Chloroquine in IDH1/2-mutated Solid Tumors (NCT02496741) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-11-01 |
| Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation (NCT02273739) | Celgene | 2014-12-08 |
| A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas (NCT02008019) | Centre Leon Berard | 2014-08-14 |
| Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation (NCT02073994) | Institut de Recherches Internationales Servier | 2014-03-01 |
| IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 (NCT01609179) | Infinity Pharmaceuticals, Inc. | 2012-03-01 |
| Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors (NCT01560260) | National Cancer Institute (NCI) | 2012-03-01 |
| Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum (NCT02587169) | Broto, Javier Martín, M.D. | 2012-01-01 |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI (NCT01336803) | Heike E Daldrup-Link | 2011-08-01 |
| Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma (NCT01330966) | Emerald Clinical Inc. | 2011-04-01 |
| Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base (NCT01182753) | Heidelberg University | 2010-08-01 |
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452) | National Cancer Institute (NCI) | 2010-06-01 |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery (NCT01553539) | Wake Forest University Health Sciences | 2009-10-01 |
| Trial of Dasatinib in Advanced Sarcomas (NCT00464620) | Sarcoma Alliance for Research through Collaboration | 2007-05-01 |
| Proton Beam Therapy for Chondrosarcoma (NCT00496522) | M.D. Anderson Cancer Center | 2006-04-28 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241) | National Cancer Institute (NCI) | 1999-10-01 |
| Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine (NCT00592748) | Massachusetts General Hospital | 1999-06-01 |
| S9624 Ifosfamide in Treating Patients With Meningeal Tumors (NCT00003292) | SWOG Cancer Research Network | 1998-07-01 |
| Tazemetostat Expanded Access Program for Adults With Solid Tumors (NCT03874455) | Epizyme, Inc. | |
| BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast (NCT04091295) | Aveni Foundation | |